Show items per page
Elements: 92
Page 1 on 2
 TitleAuthors / EditorsDate
add to browser selection
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis Radner, Helga; Chatzidionysiou, Katerina; Nikiphorou, Elena; Gossec, Laure; ... Askling, Johan 2018
add to browser selection
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries Curtis, Jeffrey R.; Jain, Archana; Askling, Johan; Bridges, S Louis Jr; ... Zink, Angela 2010
add to browser selection
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial Genevay, Stéphane; Finckh, Axel; Zufferey, P; Viatte, Sébastien; ... Gabay, Cem 2012
add to browser selection
Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial Genevay, Stéphane; Viatte, Sébastien; Finckh, Axel; Zufferey, Pascal; ... Gabay, Cem 2010
add to browser selection
Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee Bas, Sylvette; Finckh, Axel; Puskas, Gabor Janos; Suva, Domizio; ... Luebbeke-Wolff, Anne 2014
add to browser selection
An Internet-based technique for the identification of persons with symptoms of inflammatory polyarthritis of less than 12 weeks Liang, Matthew H; Couto, Maura C M; Duarte, Cátia C M; Gall, Victoria; ... Sayre, Eric C 2015
add to browser selection
Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study Möller, Burkhard; Scherer, Almut; Förger, Frauke; Villiger, Peter M; Finckh, Axel 2014
add to browser selection
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis Vuilleumier, Nicolas; Bas, Sylvette; Pagano, Sabrina; Montecucco, Fabrizio; ... Gabay, Cem 2010
add to browser selection
Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria Zufferey, Pascal; Ghosn, Jacqueline; Becce, Fabio; Ciurea, Adrian; ... So, Alexander K 2015
add to browser selection
At the horizon of innovative therapy in rheumatology: new biologic agents Finckh, Axel; Gabay, Cem 2008
add to browser selection
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis Waldburger, Jean-Marc; Palmer-Lourenco, Gaby; Seemayer, Christian Alexander; Lamacchia, Céline; ... Gabay, Cem 2011
add to browser selection
BMI and severity of clinical and radiographic signs of hip osteoarthritis Luebbeke-Wolff, Anne; Duc, Sylvain; Garavaglia, Guido; Finckh, Axel; Hoffmeyer, Pierre 2009
add to browser selection
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA) Iannone, Florenzo; Courvoisier, Delphine S; Gottenberg, Jacques Eric; Hernandez, Maria Victoria; ... Finckh, Axel 2017
add to browser selection
Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis Gottenberg, J E; Courvoisier, D S; Hernandez, M V; Iannone, F; ... Finckh, Axel 2016
add to browser selection
Chagas disease and systemic autoimmune diseases among Bolivian patients in Switzerland Jackson, Yves-Laurent Julien; Pula, Drenusha Vieira de Mello; Finckh, Axel; Chizzolini, Carlo; Chappuis, François 2018
add to browser selection
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study Möller, Burkhard; Pruijm, Menno; Adler, Sabine; Scherer, Almut; ... Finckh, Axel 2015
add to browser selection
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies Bandelier, Cédric; Guerne, Pierre-André; Genevay, Stéphane; Finckh, Axel; Gabay, Cem 2009
add to browser selection
Comparative effectiveness of rheumatoid arthritis therapies Finckh, Axel 2010
add to browser selection
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis Buckley, Felicity; Finckh, Axel; Huizinga, Tom W J; Dejonckheere, Fred; Jansen, Jeroen P 2015
add to browser selection
Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis Du Pan, Sophie Martin; Dehler, Silvia; Ciurea, Adrian; Ziswiler, Hans-Rudolf; ... Finckh, Axel 2009
add to browser selection
Complications cardio-vasculaires dans les maladies auto-immunes Finckh, Axel 2013
add to browser selection
Cost-effectiveness of biologics in early rheumatoid arthritis Finckh, Axel; Bansback, Nick; Liang, Matthew H. 2010
add to browser selection
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients Singwe-Ngandeu, Madeleine; Finckh, Axel; Bas, Sylvette; Tiercy, Jean-Marie; Gabay, Cem 2010
add to browser selection
Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients Martin-du-pan, Sophie Marie Catherine; Scherer, Almut; Gabay, Cem; Finckh, Axel 2012
add to browser selection
Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life Chaigne, Benjamin; Finckh, Axel; Alpizar-Rodriguez, Deshire; Courvoisier, Delphine; ... Chizzolini, Carlo 2017
add to browser selection
Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry Zufferey, Pascal; Dudler, Jean; Scherer, Almut; Finckh, Axel 2013
add to browser selection
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency Martin, Praxedis Sina; Talabot-Ayer, Dominique; Seemayer, Christian Alexander; Vigne, Solenne; ... Palmer-Lourenco, Gaby 2013
add to browser selection
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion Walker, Ulrich A; Courvoisier, Delphine; Dudler, Jean; Aeberli, Daniel; ... Finckh, Axel 2011
add to browser selection
Do synovial leptin levels correlate with pain in end stage arthritis? Luebbeke-Wolff, Anne; Finckh, Axel; Puskas, Gabor Janos; Suva, Domizio; ... Hoffmeyer, Pierre 2013
add to browser selection
Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM) Mueller, Ruediger B; Reshiti, Nazim; Kaegi, Toni; Finckh, Axel; ... von Kempis, Johannes 2017
add to browser selection
Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry Gabay, Cem; Riek, Myriam; Scherer, Almut; Finckh, Axel 2015
add to browser selection
Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc Genevay, Stéphane; Finckh, Axel; Payer, Michael; Mezin, Françoise; ... Guerne, Pierre-André 2008
add to browser selection
Environmental factors and hormones in the development of rheumatoid arthritis Alpizar Rodriguez, Deshire; Finckh, Axel 2017
add to browser selection
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology Dixon, William G.; Carmona, Loreto; Finckh, Axel; Hetland, Merete Lund; ... Askling, Johan 2010
add to browser selection
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis Gerlag, Danielle M; Raza, Karim; van Baarsen, Lisa G M; Brouwer, Elisabeth; ... Tak, Paul P 2012
add to browser selection
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? Finckh, Axel; Courvoisier, Delphine; Pagano, Sabrina; Bas, Sylvette; ... Vuilleumier, Nicolas 2012
add to browser selection
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists Finckh, Axel; Möller, Burkhard; Dudler, Jean; Walker, Ulrich A; ... Gabay, Cem 2012
add to browser selection
Facteurs de risque pour le développement d’une polyarthrite rhumatoïde Finckh, Axel 2014
add to browser selection
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis Alpizar Rodriguez, Deshire; Mueller, Rüdiger B; Möller, Burkhard; Dudler, Jean; ... Finckh, Axel 2017
add to browser selection
Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management Cedraschi, Christine; Desmeules, Jules Alexandre; Rapiti Aylward, Elisabetta; Baumgartner, E; ... Vischer, T L 2004
add to browser selection
Immune-mediated experimental arthritis in IL-33 deficient mice Talabot Frischknecht-Ayer, Dominique; Martin, Praxedis Sina; Seemayer, Christian Alexander; Vigne, Solenne; ... Palmer-Lourenco, Gaby 2014
add to browser selection
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis Ciurea, Adrian; Scherer, Almut; Weber, Ulrich; Exer, Pascale; ... Finckh, Axel 2016
add to browser selection
Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis Lauper, Kim; Courvoisier, Delphine S; Chevallier, Paola; Finckh, Axel; Gabay, Cem 2018
add to browser selection
Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis Salliot, Carine; Finckh, Axel; Katchamart, Wanruchada; Lu, Yan; ... Keystone, Edward 2011
add to browser selection
Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study Ditisheim, Saskia Isabel; Fournier, Nicolas; Juillerat, Pascal; Pittet, Valerie; ... Finckh, Axel 2015
add to browser selection
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients Finckh, Axel; Dudler, Jean; Wermelinger, Felix; Ciurea, Adrian; ... Bas, Sylvette 2010
add to browser selection
Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation Genevay, Stéphane; Finckh, Axel; Mezin, Françoise; Tessitore, Enrico; Guerne, Pierre-André 2009
add to browser selection
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis Palmer-Lourenco, Gaby; Talabot Frischknecht-Ayer, Dominique; Lamacchia, Céline; Toy, Dean; ... Gabay, Cem 2009
add to browser selection
Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project van Beers-Tas, Marian H; Ter Wee, Marieke M; van Tuyl, Lilian H; Maat, Bertha; ... van Schaardenburg, Dirkjan 2018
add to browser selection
Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs? Ciubotariu, Elena; Gabay, Cem; Finckh, Axel 2014
<< previous | 1 | 2 |